Ionis to present at upcoming investor conferences

IONS 11.07.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-11-13
Name of Upcoming Event:Guggenheim's Inaugural Healthcare Conference
Date of Upcoming Event:2024-11-13
Name of Upcoming Event:UBS Global Healthcare Conference
Date of Upcoming Event:2024-11-18
Name of Upcoming Event:Stifel 2024 Healthcare Conference
Date of Upcoming Event:2024-11-20
Name of Upcoming Event:Jefferies London Healthcare Conference
Date of Upcoming Event:2024-12-03
Name of Upcoming Event:Citi's 2024 Global Healthcare Conference
Date of Upcoming Event:2024-12-04
Name of Upcoming Event:Piper Sandler 36th Annual Healthcare Conference
Full Press ReleaseSEC FilingsOur IONS Tweets

About Gravity Analytica

Recent News

    Recent Filings

    • 01.17.2025 - 4 Statement of changes in beneficial ownership of securities
    • 01.16.2025 - 144 Report of proposed sale of securities

    CARLSBAD, Calif.,Nov. 7, 2024/PRNewswire/ --Ionis Pharmaceuticals, Inc.(Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

    Ionis logo (PRNewsfoto/Ionis Pharmaceuticals, Inc.)

    • Guggenheim'sInaugural Healthcare ConferenceonWednesday, November 13, 2024
    • UBS Global Healthcare ConferenceonWednesday, November 13, 2024
    • Stifel 2024 Healthcare Conference onMonday, November 18, 2024
    • Jefferies London Healthcare ConferenceonWednesday, November 20, 2024
    • Citi's 2024 Global Healthcare Conference onTuesday, December 3, 2024
    • Piper Sandler 36thAnnual Healthcare Conference onWednesday, December 4, 2024

    A live webcast of these presentations can be accessed on the Investors & Media section of the Ionis website athttps://ir.ionis.com/events-and-presentations/upcoming-events. Replays will be available on the Ionis website within 48 hours and will be archived for a limited time.

    AboutIonis PharmaceuticalsFor three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients.

    To learn more about Ionis, visitIonis.comand follow us onX (Twitter)andLinkedIn.

    Ionis Pharmaceuticals Investor Contact:D. Wade Walke, Ph.D. –ir@ionis.com– 760-603-2331

    Ionis Pharmaceuticals Media Contact:Hayley Soffer–media@ionis.com– 760-603-4679

    CisionView original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-302297951.html

    SOURCEIonis Pharmaceuticals, Inc.

    Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com